extractX Ltd. Signs Letter of Intent with Canurta Therapeutics: Accelerating Strategic Growth and CSE Listing via Amalgamation Toronto, Ontario – June 23, 2025 extractX Ltd., a leading provider of advanced...

extractX Ltd. Adapts its Pricing to Expanding Market Conditions Niagara, ON – April 7, 2025 extractX Ltd. (“extractX” or the “Company”), – announced today that they have adjusted their business...

extractX Ltd. Announces Salus Bioceutical (Thailand) Co. Ltd. have signed an Agreement to extend their Service Agreement with an Intent to Buy the Lab in 2025. Niagara, ON – February...